A pilot study of immunization with interleukin-2 secreting allogeneic HLA-A2 matched renal cell carcinoma cells in patients with advanced renal cell carcinoma. Academic Article uri icon

Overview

publication date

  • December 1, 1992

Research

keywords

  • Antigens, Neoplasm
  • Carcinoma, Renal Cell
  • Genetic Therapy
  • HLA-A2 Antigen
  • Immunologic Factors
  • Immunotherapy, Active
  • Interleukin-2
  • Kidney Neoplasms
  • Recombinant Fusion Proteins
  • Tumor Cells, Cultured

Identity

Scopus Document Identifier

  • 0027032428

PubMed ID

  • 1482709

Additional Document Info

volume

  • 3

issue

  • 6